Cargando…
Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195091/ https://www.ncbi.nlm.nih.gov/pubmed/32348824 http://dx.doi.org/10.1016/j.jaad.2020.04.112 |
| _version_ | 1783528468809515008 |
|---|---|
| author | Grant-Kels, Jane M. |
| author_facet | Grant-Kels, Jane M. |
| author_sort | Grant-Kels, Jane M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7195091 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | by the American Academy of Dermatology, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71950912020-05-02 Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis” Grant-Kels, Jane M. J Am Acad Dermatol Article by the American Academy of Dermatology, Inc. 2020-07 2020-04-26 /pmc/articles/PMC7195091/ /pubmed/32348824 http://dx.doi.org/10.1016/j.jaad.2020.04.112 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Grant-Kels, Jane M. Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis” |
| title | Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis” |
| title_full | Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis” |
| title_fullStr | Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis” |
| title_full_unstemmed | Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis” |
| title_short | Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis” |
| title_sort | response to: “risks of hydroxychloroquine use for covid-19 prophylaxis” |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195091/ https://www.ncbi.nlm.nih.gov/pubmed/32348824 http://dx.doi.org/10.1016/j.jaad.2020.04.112 |
| work_keys_str_mv | AT grantkelsjanem responsetorisksofhydroxychloroquineuseforcovid19prophylaxis |